I could not be prouder for this paper bit.ly/2JxNJUm "Isabl, a digital biobank for processing multimodal patient data" published this week in BMC Bioinformatics led by @jsmedmar (demo.isabl.io). A thread as to why this is important.1/

👇🏼👇🏼👇🏼

Just published #OnlineFirst: A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in #Myeloid Neoplasms. Cleveland Clinic Lerner Research Institute Cleveland Clinic Munich Leukemia Laboratory Lurie Cancer Center Sylvester Comprehensive Cancer Center #MPN bit.ly/39XrdPo

Congratulations to postdoc Scott Millman, MD PhD on being selected by ASH to receive an ASH Scholar Award! Scott will investigate metabolic gene dependencies in #AML. bit.ly/3slpom2 #ASHAwards

Very grateful for the support of Herbert Irving Comprehensive Cancer Center Columbia Stem Cell Initiative (CSCI) Columbia Genetics and Development Department and ASH. I stand on the shoulders of giants Ross Levine. hematology.org/newsroom/press…

Folkss, the latest #OpenFlow session (with amazing @CrickTraining) is on YouTube! "Full Spectrum #FlowCytometry Part II - Panel Design & Troubleshooting" using Cytek Biosciences #Aurora. check this out: bit.ly/2LVVVPg #flowcyto #flownerds #science #flowedu

Amidst the many firsts of 2021, we present our first MSKCC Center for Molecular Oncology (CMO) #Twinterview of the year, featuring Sarah Phillips Suehnholz Sarah Phillips Suehnholz of OncoKB™ and Andrea Farina @RomanoNyc of MSKCC Integrated Genomics Operation!

Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer | Memorial Sloan Kettering Cancer Center mskcc.org/news/sloan-ket…

The Tow Center for #DevelopmentalOncology officially launches today! Congrats to Director Alex Kentsis MD, PhD and all others involved. ow.ly/tSG650DfGBv

A new year for new science and a new science publishing model: Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia ☛ alexkentsis.net/new-year-new-s…

Please RT & join us on 11th Feb 4-5:30pm CET our extensive panel of experts discuss COVID-19 vaccination and immune challenges for leukemia patients. This webinar is co-hosted by CLL Advocates Network and Acute Leukemia Advocates Network (ALAN) FREE to register here: zoom.us/webinar/regist…

Very happy to see our paper on enhancer hijacking determining MYCN amplicon architecture in neuroblastoma chosen for an Editor's Highlight. If you're attending #ANR2021, it's great timing to see this presented w/kons and Anton Henssen tomorrow! nature.com/collections/aa…

Research Shows How Common Feature of Blood Cancers Can Be Targeted mskcc.org/news/research-…

Check out this Excellent work from Michael Kharas MSK and others out Cancer Cell! Congrats to all!

Excited to share our collaboration w/ Robert K. Bradley demonstrating that pharmacologic modulation of splicing induces immunogenic neoantigens and augments response to checkpoint blockade. Jointly led by LuLab, Emma De Neef, @jdthomaslab. Out today in @Cell: cell.com/cell/fulltext/…

TOMORROW IS THE DEADLINE FOR FASEB 2021 ABSTRACTS JUNE 25TH 2021 FASEB HEME MALIGNANCIES!!! SPEAKER SLOTS, TEASER TALKS, AND POSTERS ALL STILL OPEN!! ww2.eventrebels.com/er/EventHomePa…

That’s an amazing illustration! You’ve got great talent. And of course congrats to Abdel-Wahab Lab & Robert K. Bradley!

C